Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by João Rovisco
Eligibility Criteria for Biologic Disease-Modifying Antirheumatic Drugs in Axial Spondyloarthritis: Going Beyond BASDAI
RMD Open
Rheumatology
Allergy
Immunology
Related publications
Switching Biological Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis: Results From a Systematic Literature Review
RMD Open
Rheumatology
Allergy
Immunology
Hypersensitivity Reactions to Biologic Disease Modifying Antirheumatic Drugs: Experience From the TTSH Singapore Biologics Registry
Clinical and Translational Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Assessing the Effectiveness of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis &Ndash; A Systematic Review
Psoriasis: Targets and Therapy
Dermatology
Rheumatology
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics
Pharmacology
Persistence With Biological Disease-Modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
Drugs - Real World Outcomes
Pharmacology
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Arthritis Care and Research
Rheumatology
